UNSPSC 51283402: Adicillin or penicillin n

This classification denotes a penicillin antibiotic with the molecular formula C14H21N3O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NOF9U9EYQ4, chemically known as 6-(5-amino-5-carboxyvaleramido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but generally known as adicillin, which bears US NIH Compound Identifier 71724. European Medicines Agency schedules Adicillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05269MIG.

The term ADICILLIN is an International Non-Proprietary Name. ADICILLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Adicillin or penicillin n bears US NLM identifiers UMLS ID C0070233 and NCI Concept Code C72659. SMILES: S1C2N(C(C1(C)C)C(=O)O)C(=O)C2NC(=O)CCCC(N)C(=O)O.

UNSPSC 51283402 Adicillin or penicillin n is a Commodity code that nominally covers penicillin-class antibiotics, but recent state and local procurement activity under this code shows minimal direct alignment with that scope. The recent opportunities tagged to the code involve naloxone (an opioid antagonist used in overdose response) and antibiotic products including doxycycline hyclate and ciprofloxacin hydrochloride—neither of which is penicillin or a penicillin derivative. State and local health departments and county public health authorities appear to be the primary issuing bodies, pursuing pharmaceutical procurement through both direct competitive bidding and cooperative purchasing consortia such as MMCAP Infuse.

Recent activity is sparse and geographically limited. Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 via IFB (Invitation for Bid) for doxycycline hyclate 100 mg and ciprofloxacin hydrochloride 500 mg tablets over a three-year contract term with renewal options. Seminole County, Florida issued an IFB on June 30, 2026 (due July 26, 2023 per the source date) for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The code shows limited recent state and local activity and poor taxonomic alignment with the products actually being bought; business development professionals should verify coding accuracy with issuing bodies before pursuing opportunities tagged to this code.